Sign In
Free Newsletter
Merck to acquire Terns Pharmaceuticals in $6.7B oncology deal
Merck's addition of Terns Pharmaceuticals will help expand the buyer's pipeline ahead of the expiration for its Keytruda patent in 2028.
Novartis advances $23B US manufacturing plan in Florida
The new, $70 million radioligand therapy facility is part of the company's $23 billion plan to expand domestic drug production.
J&J to acquire Connecticut biotech in $3.05B oncology deal
Johnson & Johnson's latest target, Halda Therapeutics, will add prostate cancer therapy HLD-0915 along with other early-stage assets.
Genmab to acquire Merus in $8B biotech deal
The move will add a treatment for head and neck cancer to the Plainsboro-based buyer's pipeline.
